When Testosterone Fell, COVID-19 Became Deadlier.
A Scientific Story Connecting
Hormones, Immunity & PHYSTA® Tongkat Ali.
That changed in July 2021, when
Professor Andrea Salonia and his team from San Raffaele University Hospital,
Milan, presented a landmark finding at the 36th Annual European Association of
Urology Congress (EAU21).
What they discovered shocked even
seasoned clinicians.
“I have never seen anything like
this in my 25 years in the field.”
Prof. Andrea Salonia, EAU21, 2021
The Milan Discovery: Testosterone
& COVID-19 Severity
In a cohort of 286 men
hospitalized with COVID-19:
·
89.8% had low testosterone (hypogonadism) at
admission
·
Only 14.9% of healthy controls showed low
testosterone
The lower the testosterone level,
the higher the risk of:
·
Severe disease
·
Death
Ref : COVID-19
Is Associated With Low Testosterone in Men.
While the study did not
definitively determine whether COVID-19 caused low testosterone or exploited
it, the signal was unmistakable:
·
Low testosterone was strongly associated with
poor COVID-19 outcomes and mortality in men.
Men with low testosterone more likely to die from Covid-19.
This was not an isolated
observation. Independent reports (including EurekAlert) reinforced the same
conclusion:
·
men with low testosterone were significantly
more likely to die from COVID-19.
·
Why Testosterone Matters in Viral Infections
Testosterone is not merely a
“male hormone.” Scientifically, it plays critical roles in:
·
Immune regulation (T-cell balance, cytokine
modulation)
·
Inflammation control (preventing cytokine
overreaction)
·
Muscle, lung & metabolic resilience
·
Stress hormone (cortisol) suppression
When testosterone collapses:
Inflammation rises
Immune response becomes
dysregulated
Recovery capacity weakens
COVID-19 did not just attack the
lungs it exposed metabolic & hormonal vulnerabilities, particularly in
aging or stressed men.
PHYSTA® Tongkat Ali: Where
Hormonal Science Meets Antiviral Evidence
This is where PHYSTA®, the
standardized water extract of Eurycoma longifolia (Tongkat Ali), becomes
scientifically relevant not as speculation, but through published evidence.
1. Clinically Proven Testosterone
Support
PHYSTA® is one of the most
clinically studied Tongkat Ali extracts globally, with human trials
demonstrating:
Restoration of testosterone
levels in men with deficiency
Reduction of cortisol (stress
hormone)
Improvement in energy, vitality
& physiological resilience
These effects directly address
the risk profile identified in severe COVID-19 patients.
2. Direct Antiviral Activity
Against SARS-CoV-2 (In Vitro)
In May 2024, a peer-reviewed
study published in the
Malaysian Journal of
Pharmaceutical Sciences (Vol. 22, No. 1, pp. 77–86) reported:
“Antiviral activity of PHYSTA® standardized water extract of Eurycoma longifolia against SARS-CoV-2: An in vitro study”
Antiviral Activity of Physta®, Standardised Water Extract of Eurycoma longifolia against SARS-CoV-2: An in vitro Study
Source: Universiti Sains Malaysia
https://share.google/Ky3KJJ5TrNaso7M3u
Conducted by:
Tropical Infectious Diseases
Research & Education Centre (TIDREC)
Key findings:
·
PHYSTA® inhibited SARS-CoV-2 replication in Vero
cells
·
IC₅₀: 36.3 μg/mL (50% viral growth reduction)
·
No cytotoxicity at effective antiviral
concentrations
·
Clear suppression of viral plaque formation
within 72 hours
·
Favorable Selectivity Index (SI), indicating
safety vs efficacy balance
Mechanistically, the antiviral
activity was attributed to:
·
Saponins interfering with viral capsid protein
synthesis
·
Immunomodulatory effects reducing excessive
inflammation
3. Intellectual Property
Protection
This discovery is further
reinforced by a registered patent:
·
Title: Use of Eurycoma longifolia extract
against Coronavirus
·
This reflects novelty, scientific merit & translational
potential, not anecdotal use.
Connecting the Evidence Carefully
& Scientifically
What the science allows us to say
responsibly:
·
Severe COVID-19 is strongly associated with low
testosterone in men
·
PHYSTA® is clinically proven to support
testosterone
·
PHYSTA® has peer-reviewed in-vitro evidence
showing inhibition of SARS-CoV-2
·
PHYSTA® demonstrates immune-modulating and
anti-inflammatory properties
What science does not claim:
·
PHYSTA® is not positioned as a drug or a cure
·
In-vitro antiviral activity does not replace
clinical COVID-19 treatment
The COVID-19 pandemic revealed a
critical but under-recognized factor in men’s vulnerability: hormonal
resilience, particularly testosterone status.
The convergence of:
·
European clinical observations (EAU21, Milan)
·
Hormonal biology
·
Peer-reviewed antiviral laboratory evidence
Clinically validated Tongkat Ali
standardization (PHYSTA®)
places PHYSTA® in a unique
scientific position not as speculation, but as a biologically plausible,
evidence-supported natural intervention worthy of serious academic &
clinical attention.
PHYSTA® is currently among the
very few standardized herbal extracts with both:
·
Human clinical evidence for testosterone support
&
·
Published in-vitro evidence against SARS-CoV-2
This does not close the chapter it
opens a new one for future translational, clinical & preventive research at
the intersection of men’s health, immunity & viral resilience.




.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)

.jpeg)
.jpeg)
.jpeg)
.jpeg)

.jpeg)